That's great news. The trouble with HCT is that they don't back their claims with real-world scientific studies until every player in the game has gotten ahead of them and they can no longer make a market leading impact. This is what happened with the HVAC and Natshield. It did work against the human strain but they did the studies and released the science too late to make an impact in market share. They failed to get TGA approval in Australia, making it just about worthless to any government organisation or organisation that needs to satisfy government criteria (lets just say everyone).
So yes, HCT have a product that aims to control COVID-19 within one of the key environments where it grows and spreads from, the nose, but who knows or even cares about it other than shareholders because the company have not obtained effectiveness data and have not marketed it aggressively enough.
- Forums
- ASX - By Stock
- HCT
- Ann: First Commercial Order from Country Farms/Starbucks
Ann: First Commercial Order from Country Farms/Starbucks, page-46
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HCT (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.3¢ |
Change
-0.001(4.17%) |
Mkt cap ! $6.412M |
Open | High | Low | Value | Volume |
2.3¢ | 2.3¢ | 2.3¢ | $20 | 863 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 30000 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.3¢ | 184832 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 30000 | 0.019 |
1 | 508000 | 0.008 |
1 | 100000 | 0.006 |
2 | 435000 | 0.005 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.023 | 184832 | 1 |
0.027 | 80000 | 1 |
0.028 | 49999 | 1 |
0.029 | 78000 | 2 |
0.030 | 12000 | 1 |
Last trade - 10.04am 04/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
HCT (ASX) Chart |